Clinical Trials Browser

INDUSTRY × Immunomodulating Agents × Other hematologic neoplasm × Clear all

NCT05828459 2025-03-20

First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors

Phase 1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms